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Acute intoxication with many of the 
antiepileptic drugs may present with men-
tal symptoms (encephalopathy, confusion, 
psychosis), sometimes in the absence of 
other clinical signs such as nystagmus, 
dysarthria or ataxia etc. (Logan and 
Freeman 1969 ; McDonal and Bolman 
1975 ; Ahmad et al. 1975 ; Reynolds 
1982). Atypical anticonvulsant toxicity in 
mentally retarded children have been re-
ported but not in a specific association with 
mental retardation (Logan and Freeman 
1969 ; Dahl 1967 ; Hoaken et al. 1963 ; 
Prensky et al. 1971). In this paper, we 
present two patients with chronic organic 
brain syndrome or borderline mental 
retardation who developed a functional 
psychosis associated with anticonvulsant 
toxcity. 
Casel 
Mr B.C, a 11 year old child with bor-
derline mental retardation, had psychomo-
ter seizures since age of 6 years for which he 
was given carbamazepine 400 mg / day. Mr 
BC was admitted in Paediatric ward after he 
accidently took an overdose. He had slurred 
speech and bizarre behaviour. All medica-
tions were stopped and there was minimal 
improvement over next one week. An EEG 
revealed moderate slow wave activity with-
out evidence of an epileptic focus. It was 
thought that whatever toxic reaction there 
was, had subsided, so Mr BC was transfer-
red to psychiatry ward for control of his 'hys-
terical psychosis' (as diagnosed by Pediatri-
cian for not being able to find an organic 
basis for the symptoms). The carbamaze-
pine was increased to 600 mg/day. Over the 
next several days, the psychoses worsened 
and the bizarre motor behaviour increased 
which included compulsive cleaning, force-
ful rubbing of his eyes, and choreoathetoid 
writhing of his hands and body . In addition, 
his affect became labile. He developed loos-
ening of association, delusions of persecu-
tion and self reference and auditory halluci-
nations in the presence of intact orientation 
and memory. Complete physical and neuro-
logical examination showed minimal insta-
bility on the Romberg exmination, with wri-
thing movements as described above. Two 
days later, his orientation and short term 
memory were also disturbed. The possibility 
of toxic psychosis was made (however, 
blood levels of drug were not determined), 
so dosage of carbamazepine was decreased. 
Mr BC's psychosis cleared within five days. 
Case 2 
Mr ML, a 15 year old boy with border-
line retardation had an idiopathic motor 
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seizure disorder that started in infancy. He 
had been treated with phenytoin 100 tid. 
He was admitted because of frequent 
spells of choreoathetoid movements of the 
extremities, falling and crawling on the 
floor, bizarre stereotyped movements and 
autistic thinking, with intact memory and 
orientation. CT scan and EEG were nor-
mal. The neurological examination 
showed minimal instability on the Rom-
berg .examination with bizarre stereotyped 
movements. The blood level of phenytoin 
was 15/ng/ml (normal 10-12/^ig/ml). The 
patient was given haloperidol 20mg/day, 
without improvement. The patient's 
phenytoin dosage was decreased to 100 mg 
twice daily (blood level 10/xg/ml). The 
psychosis cleared up within five days. Be-
fore coming to psychiatry OPD, Mr ML 
was taking anticonvulsants (phenytoin) er-
ratically in the past and at times in exces-
sive quantities. 
Discussion 
Landolt (1958) described a subgroup 
of patients with usually short-lived 
episodes of psychosis, which seemed to ap-
pear (alternate) at times of good control of 
seizures, sometimes but not always, as-
sociated with 'forced normalization' of the 
EEG. Some workers have reported less 
well recognized subacute deterioration in 
mental function (Subacute encephalo-
pathy, dementia, pseudodegenerative dis-
order) without more classical signs of to-
xicity, which is associated with phenytoin 
and barbiturates (Reynolds 1970; Trimble 
and Reynolds 1976). These patients mild 
chronic organic brain syndrome or mild 
mental retardation appeared to make 
them more sensitive to the toxic effects of 
anticonvulsants and to an atypical presen-
tation i.e., the appearance of functional 
illness (Franks and Richter 1979). These 
two patients appeared schizophrenic at 
first, with symptoms of thought disorder, 
inappropriate affect, bizarre behaviour 
and choreoathetoid movements in a clear 
sensorium. These atypical presentations 
did not occur in response to a specific an-
ticonvulsant but rather were found with 
phenytoin, carbamazepine, primidone and 
clonazepam (Franks and Richter 1979). 
The neurological toxicity induced by an-
ticonvulsants have been reported with 
normal blood levels (Brooker and Dar-
cey 1973) as was seen in Case 2. In some 
patients, even the conventional doses of 
anticonvulsants may produce toxic blood 
levels (Logan and Freeman 1969). 
One could possibly explain these 
psychotic episodes as a coincidental func-
tional psychosis in association with an-
ticonvulsant toxicity. This seems unlike, 
however, given the dramatic improve-
ment in the psychosis when the dosage of 
anticonvulsant medication was lowered 
(also reported by Reynolds 1970). Rais-
ing the anticonvulsant dosage would ans-
wer the question, but obvious ethical is-
sues prevented this. We hope that these 
findings will help in evaluating those pa-
tients who are being treated for both a 
seizure disorder and schizophrenia. 
Some of these patients may simply be suf-
fering from anticonvulsant toxicity 
rather than the functional illness. Cauti-
ously reducing the medication could 
lead, as in the above cases, to dramatic 
improvement. 
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